Royce & Associates LP Harvard Bioscience Inc Transaction History

Royce & Associates LP

$9.25 Billion
Q2 2025

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$0.57 - $2.19 $106,715 - $410,011	-187,220 Reduced 9.53%	1,777,894 $1.01 Million
Q4 2024 Feb 10, 2025	BUY	$2.02 - $2.82 $1.04 Million - $1.45 Million	513,664 Added 35.39%	1,965,114 $4.15 Million
Q3 2024 Nov 06, 2024	BUY	$2.64 - $3.54 $26,400 - $35,400	10,000 Added 0.69%	1,451,450 $3.9 Million
Q2 2024 Aug 13, 2024	BUY	$2.77 - $4.63 $256,698 - $429,066	92,671 Added 6.87%	1,441,450 $4.11 Million
Q1 2024 May 13, 2024	SELL	$4.02 - $5.39 $410,240 - $550,049	-102,050 Reduced 7.03%	1,348,779 $5.72 Million
Q4 2023 Feb 12, 2024	BUY	$4.0 - $5.49 $160,800 - $220,698	40,200 Added 2.85%	1,450,829 $7.76 Million
Q3 2023 Nov 09, 2023	BUY	$4.0 - $5.82 $39,200 - $57,036	9,800 Added 0.7%	1,410,629 $6.07 Million
Q2 2023 Aug 07, 2023	SELL	$4.19 - $6.16 $160,699 - $236,254	-38,353 Reduced 2.66%	1,400,829 $7.69 Million
Q1 2023 May 04, 2023	BUY	$2.45 - $4.22 $35,081 - $60,426	14,319 Added 1.0%	1,439,182 $6.05 Million
Q4 2022 May 23, 2023	SELL	$2.12 - $2.86 $30,356 - $40,952	-14,319 Reduced 0.99%	1,424,863 $3.95 Million
Q4 2022 Feb 13, 2023	SELL	$2.12 - $2.86 $155,608 - $209,924	-73,400 Reduced 4.9%	1,424,863 $3.95 Million
Q3 2022 Nov 03, 2022	SELL	$2.33 - $3.92 $284,260 - $478,240	-122,000 Reduced 7.53%	1,498,263 $3.84 Million
Q2 2022 Aug 04, 2022	SELL	$3.28 - $6.42 $215,496 - $421,794	-65,700 Reduced 3.9%	1,620,263 $5.83 Million
Q1 2022 May 05, 2022	SELL	$5.16 - $7.14 $656,352 - $908,208	-127,200 Reduced 7.02%	1,685,963 $10.5 Million
Q4 2021 Feb 07, 2022	SELL	$6.37 - $8.18 $32,869 - $42,208	-5,160 Reduced 0.28%	1,813,163 $12.8 Million
Q3 2021 Nov 10, 2021	SELL	$6.98 - $8.47 $1.37 Million - $1.66 Million	-195,627 Reduced 9.71%	1,818,323 $12.7 Million
Q2 2021 Aug 06, 2021	BUY	$5.44 - $8.4 $522,240 - $806,400	96,000 Added 5.01%	2,013,950 $16.8 Million
Q1 2021 May 10, 2021	BUY	$3.91 - $6.99 $986,688 - $1.76 Million	252,350 Added 15.15%	1,917,950 $10.5 Million
Q4 2020 Feb 08, 2021	BUY	$3.0 - $4.5 $215,625 - $323,437	71,875 Added 4.51%	1,665,600 $7.15 Million
Q3 2020 Nov 12, 2020	SELL	$2.75 - $4.2 $772,406 - $1.18 Million	-280,875 Reduced 14.98%	1,593,725 $4.8 Million
Q2 2020 Aug 07, 2020	BUY	$2.12 - $3.14 $410,432 - $607,904	193,600 Added 11.52%	1,874,600 $5.81 Million
Q1 2020 May 12, 2020	BUY	$1.42 - $3.29 $42,600 - $98,700	30,000 Added 1.82%	1,681,000 $3.72 Million
Q4 2019 Feb 06, 2020	SELL	$2.45 - $3.25 $530,180 - $703,300	-216,400 Reduced 11.59%	1,651,000 $5.04 Million
Q3 2019 Nov 13, 2019	BUY	$1.59 - $3.47 $59,784 - $130,472	37,600 Added 2.05%	1,867,400 $5.74 Million
Q2 2019 Aug 12, 2019	BUY	$1.93 - $4.59 $192,228 - $457,164	99,600 Added 5.76%	1,829,800 $3.66 Million
Q4 2018 Feb 11, 2019	BUY	$3.03 - $5.0 $395,415 - $652,500	130,500 Added 8.16%	1,730,200 $5.5 Million
Q3 2018 Nov 13, 2018	BUY	$5.0 - $6.65 $173,500 - $230,755	34,700 Added 2.22%	1,599,700 $8.4 Million
Q2 2018 Aug 09, 2018	BUY	$4.2 - $5.95 $1.14 Million - $1.61 Million	270,306 Added 20.88%	1,565,000 $8.37 Million
Q1 2018 May 14, 2018	SELL	$3.3 - $5.15 $667,939 - $1.04 Million	-202,406 Reduced 13.52%	1,294,694 $6.47 Million
Q4 2017 Feb 09, 2018	SELL	$3.08 - $3.8 $186,340 - $229,900	-60,500 Reduced 3.88%	1,497,100 $4.94 Million
Q2 2017 Aug 07, 2017	BUY	N/A	1,557,600	1,557,600 $3.97 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

23.2M

Call Options Held

8.7K

Put Options Held

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $22.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account